Biography
Yerkebulan Algodzhin, born on 27.08.1973 in Kazakhstan, is a pulmonologist (phthisiatrist) with 27 years of experience. He graduated from the Karaganda Medical Academy in 1997, specializing in Pediatrics, and completed an internship in phthisiatry. Since 2019, he has served as the Director of Partners In Health in Kazakhstan. Previously, he was the Medical Director for the endTB project and held various roles in the Regional Tuberculosis Dispensary of Karaganda. He has extensive experience in TB treatment, training healthcare providers, and contributing to international TB projects. He is fluent in Kazakh, Russian, and English
Key Impacts
Outcomes of short-course regimens in the treatment of drug-resistant TB in people with TB & HIV, TB & hepatitis, TB & HIV & hepatitis, and TB in Kazakhstan
​TB-only patients had the highest success rate (85.5%), followed by TB+HIV (82.6%), TB+Hepatitis (81.2%), and TB+HIV+Hepatitis (64.1%).The highest mortality was in TB+HIV+Hepatitis (7.7%).Adverse events were most frequent in TB+HIV+Hepatitis (88.6%).Short-course regimens are effective for RR/MDR-TB, especially in patients without co-infections. Co-infected patients had lower success rates and higher adverse events, highlighting the need for tailored approaches and antiviral therapy in TB+Hepatitis cases.
Source: Conference 2024